Evaluation of safety and pharmacodinamy of Terap C: a vaccine preparation for therapeutic use in the treatment of chronic hepatitis caused by hepatitis C virus. Phase II clinical trial controlled, randomized, blinded.
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2016
At a glance
- Drugs CIGB 230 (Primary) ; Interferon alpha-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Sep 2011 New trial record